(Q35622819)

9 August 2017

1 reference

title

Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow (English)

1 reference

9 August 2017

Michael Girardi

1

1 reference

PubMed ID

14710891

9 August 2017

Robert Knobler

series ordinal

2

1 reference

PubMed ID

14710891

9 August 2017

Richard Edelson

series ordinal

3

1 reference

9 August 2017

1 December 2003

1 reference

Hematology / Oncology Clinics of North America

9 August 2017

1 reference

9 August 2017

17

1 reference

9 August 2017

6

1 reference

9 August 2017

1391-1403

1 reference

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photopheresis for the treatment of lupus erythematosus. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Treatment of severe atopic dermatitis with extracorporeal photopheresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Treatment of psoriatic arthritis by extracorporeal photochemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Treatment of psoriatic arthritis with extracorporeal photochemotherapy and conventional psoralen-ultraviolet A irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photopheresis in the red man or pre-Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Successful treatment of a patient with chronic Lyme arthritis with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Pemphigus vulgaris treated with photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy: A potentially useful treatment for scleromyxedema

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Successful treatment of heart transplant rejection with photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Renal allograft rejection controlled by photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photopheresis for chronic rejection of lung allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photopheresis for the treatment of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photopheresis therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

[Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis in Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy--the Columbia Presbyterian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Circulating CD4+CD7− Lymphocyte Burden and Rapidity of Response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photopheresis: clinical applications and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photopheresis and the red man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Cell membrane DNA: a new target for psoralen photoadduct formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Increased surface expression of class I MHC molecules on immunogenic cells derived from the xenogenization of P815 mastocytoma cells with 8-methoxypsoralen and long-wavelength ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Parenteral administration of 8-methoxypsoralen in photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Release of Oxygen-Free Radicals by Neutrophils Is Reduced by Photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

An animal model for extracorporeal photochemotherapy based on contact hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Suppression of anti-skin-allograft response by photodamaged effector cells--the modulating effects of prednisolone and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Induction of human tumor-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900106-0

7 January 2021

10.1016/S0889-8588(03)00106-0

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14710891